BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6352018)

  • 1. Collagen degradation by metastatic variants of Lewis lung carcinoma: cooperation between tumor cells and macrophages.
    Henry N; van Lamsweerde AL; Vaes G
    Cancer Res; 1983 Nov; 43(11):5321-7. PubMed ID: 6352018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
    Nakanishi H; Oguri K; Takenaga K; Hosoda S; Okayama M
    Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
    Young MR; Newby M
    Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma.
    Eisenbach L; Segal S; Feldman M
    J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-macrophage-fibroblast co-operation in the inflammatory degradation of cartilage and connective tissue.
    Vaes G; Huybrechts-Godin G; Hauser P
    Agents Actions Suppl; 1980; 7():100-8. PubMed ID: 6264765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
    Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
    J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo.
    Sutherland A; Mirjolet JF; Maho A; Parmentier M
    Cancer Gene Ther; 2007 Oct; 14(10):847-57. PubMed ID: 17599091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic enzymes in tumor metastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations.
    Eisenbach L; Segal S; Feldman M
    J Natl Cancer Inst; 1985 Jan; 74(1):87-93. PubMed ID: 2982056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced migration of tumor cells in response to collagen degradation products and tumor cell collagenolytic activity.
    Nabeshima K; Kataoka H; Koono M
    Invasion Metastasis; 1986; 6(5):270-86. PubMed ID: 3536792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a macrophage chemokinetic factor in tumor cell culture media.
    Lane RD; Kaplan AM; Snodgrass MJ; Szakal AK
    J Reticuloendothel Soc; 1982 Feb; 31(2):171-84. PubMed ID: 7062320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic heterogeneity of cells from Lewis lung carcinoma.
    van Lamsweerde AL; Henry N; Vaes G
    Cancer Res; 1983 Nov; 43(11):5314-20. PubMed ID: 6616467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
    Chambers SK; Wang Y; Gertz RE; Kacinski BM
    Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vitamin A and dexamethasone on collagen degradation in mouse mammary adenocarcinoma.
    Takahashi S; Biempica L
    Cancer Res; 1985 Jul; 45(7):3311-21. PubMed ID: 2988767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of myelomonocytic cells during differentiation into macrophages.
    Pluznik DH; Fridman R; Reich R
    Exp Hematol; 1992 Jan; 20(1):57-63. PubMed ID: 1315691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.